289 related articles for article (PubMed ID: 29346467)
1. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.
Michels KA; Pfeiffer RM; Brinton LA; Trabert B
JAMA Oncol; 2018 Apr; 4(4):516-521. PubMed ID: 29346467
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
Gwinn ML
J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
[TBL] [Abstract][Full Text] [Related]
4. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
6. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
8. Cancer of the breast and reproductive tract in relation to use of oral contraceptives.
Schlesselman JJ
Contraception; 1989 Jul; 40(1):1-38. PubMed ID: 2673658
[TBL] [Abstract][Full Text] [Related]
9. The pill and cancer: a review of the literature. A case of swings and roundabouts?
Knowlden HA
J Adv Nurs; 1990 Sep; 15(9):1016-20. PubMed ID: 2229699
[TBL] [Abstract][Full Text] [Related]
10. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å
Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812
[TBL] [Abstract][Full Text] [Related]
11. Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women's Health Initiative.
Cespedes Feliciano EM; Hohensee C; Rosko AE; Anderson GL; Paskett ED; Zaslavsky O; Wallace RB; Caan BJ
JAMA Netw Open; 2020 Sep; 3(9):e2016747. PubMed ID: 32926116
[TBL] [Abstract][Full Text] [Related]
12. Net effect of oral contraceptive use on the risk of cancer in women in the United States.
Schlesselman JJ
Obstet Gynecol; 1995 May; 85(5 Pt 1):793-801. PubMed ID: 7724116
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives and gynecologic cancer: an update for the 1990s.
Kaunitz AM
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
[TBL] [Abstract][Full Text] [Related]
14. The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.
Kok VC; Tsai HJ; Su CF; Lee CK
Int J Gynecol Cancer; 2015 Jul; 25(6):968-76. PubMed ID: 25893280
[TBL] [Abstract][Full Text] [Related]
15. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
16. Sugar-containing beverages and their association with risk of breast, endometrial, ovarian and colorectal cancers among Canadian women.
Arthur RS; Kirsh VA; Mossavar-Rahmani Y; Xue X; Rohan TE
Cancer Epidemiol; 2021 Feb; 70():101855. PubMed ID: 33220638
[TBL] [Abstract][Full Text] [Related]
17. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
[TBL] [Abstract][Full Text] [Related]
18. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study.
Colditz GA
Ann Intern Med; 1994 May; 120(10):821-6. PubMed ID: 8154642
[TBL] [Abstract][Full Text] [Related]
20. Oral Contraceptive Use and Risks of Cancer in the NIH-AARP Diet and Health Study.
Michels KA; Brinton LA; Pfeiffer RM; Trabert B
Am J Epidemiol; 2018 Aug; 187(8):1630-1641. PubMed ID: 29394309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
